SynopsisAmiodarone is an antiarrhythmic medication used to treat and prevent a number of types of irregular heartbeats. This includes ventricular tachycardia (VT), ventricular fibrillation (VF), and wide complex tachycardia, as well as atrial fibrillation and paroxysm.....
SynopsisAlbumin-based therapies such as Idelvion (CSL654 rIX-FP) by CSL Behring received marketing approval from the US FDA in March 2016 and from the EMA in May 2016. Apart from these, Albutropin (TV-1106) by Teva Pharmaceuticals, Ampion by Ampio Pharmaceuticals, and.....
SynopsisAccording to veterinary medical experts, upper respiratory infections– also called canine infectious respiratory disease (CIRD) is mainly caused in spaces occupied or visited by many pets such as boarding houses, groomers, and parks. The global Small Ani.....
SynopsisPreclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowl.....
Synopsis The global Companion Animal Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. Pet medical care is the second largest segm.....
SynopsisBeta-lactams are the antibiotics that contain intramecyclic amines in their molecules, including penicillin and cephalosporin.In recent years, the development of - lactamase inhibitors, oxyspora, thiomycin and so on. The global β-Lactamaseinhibitors mark.....
SynopsisThe global Apex Locators market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Apex Locators in various end use industries. The expanding demands from the .....
SynopsisThe global PARP Inhibitor Biomarkers Testing Product market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for PARP Inhibitor Biomarker.....
The global Peristaltic Volumetric Pumps market was valued at US$ 620 million in 2023 and is anticipated to reach US$ 851.3 million by 2030, witnessing a CAGR of 4.7% during the forecast period 2024-2030. North American market for Peristaltic Volumetric Pumps is estimat.....
SynopsisPFO catheter interventional closure is to use a catheter (a long tube) to send the occluder to the open oval hole, and then open and release the occluder to permanently close the hole on the atrial septum. The global PFO Occluder Device market was.....
